New Key Statistics Module, Z-Score and F-Score
NAS:BCYC Key Ratios
| Market Cap $ M | 1,727.60 |
| Enterprise Value $ M | 831.39 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.97 |
| Price/Sales | 27.88 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 39.00 |
| EPS (TTM) $ | -3.81 |
| Beneish M-Score | -2.39 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -19.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.20 |
| EV-to-EBITDA | -5.43 |
| PEG | -- |
| Shares Outstanding M | 68.99 |
| Net Margin (%) | -417.88 |
| Operating Margin % | -462.52 |
| Pre-tax Margin (%) | -411.92 |
| Quick Ratio | 14.77 |
| Current Ratio | 14.77 |
| ROA % (ttm) | -25.11 |
| ROE % (ttm) | -36.96 |
| ROIC % (ttm) | -238.85 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.36 |
BCYC Number of Guru Trades
BCYC Volume of Guru Trades
Gurus Latest Trades with NAS:BCYC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BCYC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bicycle Therapeutics PLC Insider Transactions
No Available Data
News about NAS:BCYC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers